All papers authored by Jindrich Cinatl
Refreshing results…
2020
Donghyuk Shin 
,
Rukmini Mukherjee ,
Diana Grewe ,
Denisa Bojkova,
Kheewoong Baek ,
Anshu Bhattacharya ,
Laura Schulz,
Marek Widera ,
Ahmad Reza Mehdipour ,
Georg Tascher ,
Paul P. Geurink ,
Alexander Wilhelm,
Gerbrand J. van der Heden van Noort ,
Huib Ovaa ,
Stefan Müller
and 7 other authors
,
Rukmini Mukherjee ,
Diana Grewe ,
Denisa Bojkova,
Kheewoong Baek ,
Anshu Bhattacharya ,
Laura Schulz,
Marek Widera ,
Ahmad Reza Mehdipour ,
Georg Tascher ,
Paul P. Geurink ,
Alexander Wilhelm,
Gerbrand J. van der Heden van Noort ,
Huib Ovaa ,
Stefan Müller
and 7 other authors
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
Download from www.nature.com
Denisa Bojkova,
Kevin Klann ,
Benjamin Koch ,
Marek Widera ,
David Krause,
Sandra Ciesek ,
Jindrich Cinatl ,
Christian Münch
,
Benjamin Koch ,
Marek Widera ,
David Krause,
Sandra Ciesek ,
Jindrich Cinatl ,
Christian Münch
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets
Download from www.nature.com
Jane L. Ward ,
Yanqi Wu,
Claudia Harflett,
Hannah Onafuye,
Delia Corol,
Charlotte Lomax,
William J. Macalpine ,
Jindrich Cinatl ,
Mark N. Wass ,
Martin Michaelis ,
Michael H. Beale
,
Yanqi Wu,
Claudia Harflett,
Hannah Onafuye,
Delia Corol,
Charlotte Lomax,
William J. Macalpine ,
Jindrich Cinatl ,
Mark N. Wass ,
Martin Michaelis ,
Michael H. Beale
Miyabeacin: A new cyclodimer presents a potential role for willow in cancer therapy
Download from www.nature.com
2016
Constanze Schneider,
Thomas Oellerich,
Hanna-Mari Baldauf ,
Sarah-Marie Schwarz,
Dominique Thomas,
Robert Flick,
Hanibal Bohnenberger,
Lars Kaderali ,
Lena Stegmann,
Anjali Cremer,
Margarethe Martin,
Julian Lohmeyer,
Martin Michaelis,
Veit Hornung,
Christoph Schliemann
and 12 other authors
,
Sarah-Marie Schwarz,
Dominique Thomas,
Robert Flick,
Hanibal Bohnenberger,
Lars Kaderali ,
Lena Stegmann,
Anjali Cremer,
Margarethe Martin,
Julian Lohmeyer,
Martin Michaelis,
Veit Hornung,
Christoph Schliemann
and 12 other authors
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.
Download from kar.kent.ac.ukMissing publications? Search for publications with a matching author name.